-+ 0.00%
-+ 0.00%
-+ 0.00%

*Imunon: Enrollment in Phase 3 OVATION 3 Study of IMNN-001 Expected to Be Completed by 1Q 2029

Dow Jones·05/12/2026 12:01:00

Please log in to view news